Cargando…

Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use

Patient: Female, 44 Final Diagnosis: Focal nodular hyperplasia Symptoms: Liver masses Medication: — Clinical Procedure: CT • MRI • Pathology Specialty: General and Internal Medicine OBJECTIVE: Rare disease BACKGROUND: Focal nodular hyperplasia (FNH) of the liver is a rare benign nodular lesion that...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukahori, Susumu, Kawano, Tetsuya, Obase, Yasushi, Umeyama, Yasuhiro, Sugasaki, Nanae, Kinoshita, Akitoshi, Fukushima, Chizu, Yamakawa, Masaki, Omagari, Katsuhisa, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683308/
https://www.ncbi.nlm.nih.gov/pubmed/31358723
http://dx.doi.org/10.12659/AJCR.916398
_version_ 1783442062682619904
author Fukahori, Susumu
Kawano, Tetsuya
Obase, Yasushi
Umeyama, Yasuhiro
Sugasaki, Nanae
Kinoshita, Akitoshi
Fukushima, Chizu
Yamakawa, Masaki
Omagari, Katsuhisa
Mukae, Hiroshi
author_facet Fukahori, Susumu
Kawano, Tetsuya
Obase, Yasushi
Umeyama, Yasuhiro
Sugasaki, Nanae
Kinoshita, Akitoshi
Fukushima, Chizu
Yamakawa, Masaki
Omagari, Katsuhisa
Mukae, Hiroshi
author_sort Fukahori, Susumu
collection PubMed
description Patient: Female, 44 Final Diagnosis: Focal nodular hyperplasia Symptoms: Liver masses Medication: — Clinical Procedure: CT • MRI • Pathology Specialty: General and Internal Medicine OBJECTIVE: Rare disease BACKGROUND: Focal nodular hyperplasia (FNH) of the liver is a rare benign nodular lesion that arises in women of reproductive age. Although a role of female hormones has been suggested, their influence on the course of FNH has remained controversial. CASE REPORT: A 44-year-old woman with a 12-year history of oral contraceptive use was referred to our hospital for examination of an asymptomatic liver mass (3 cm in diameter) identified by computed tomography. We diagnosed FNH using imaging methods and fine-needle biopsy. Oral contraceptives were discontinued because the mass increased over a period of 21 months. Four months later, the mass had decreased in size, indicating that FNH can spontaneously regress when oral contraceptives are discontinued. CONCLUSIONS: Discontinuation of oral contraceptives use can reduce the size of FNH, as in this case.
format Online
Article
Text
id pubmed-6683308
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-66833082019-08-26 Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use Fukahori, Susumu Kawano, Tetsuya Obase, Yasushi Umeyama, Yasuhiro Sugasaki, Nanae Kinoshita, Akitoshi Fukushima, Chizu Yamakawa, Masaki Omagari, Katsuhisa Mukae, Hiroshi Am J Case Rep Articles Patient: Female, 44 Final Diagnosis: Focal nodular hyperplasia Symptoms: Liver masses Medication: — Clinical Procedure: CT • MRI • Pathology Specialty: General and Internal Medicine OBJECTIVE: Rare disease BACKGROUND: Focal nodular hyperplasia (FNH) of the liver is a rare benign nodular lesion that arises in women of reproductive age. Although a role of female hormones has been suggested, their influence on the course of FNH has remained controversial. CASE REPORT: A 44-year-old woman with a 12-year history of oral contraceptive use was referred to our hospital for examination of an asymptomatic liver mass (3 cm in diameter) identified by computed tomography. We diagnosed FNH using imaging methods and fine-needle biopsy. Oral contraceptives were discontinued because the mass increased over a period of 21 months. Four months later, the mass had decreased in size, indicating that FNH can spontaneously regress when oral contraceptives are discontinued. CONCLUSIONS: Discontinuation of oral contraceptives use can reduce the size of FNH, as in this case. International Scientific Literature, Inc. 2019-07-30 /pmc/articles/PMC6683308/ /pubmed/31358723 http://dx.doi.org/10.12659/AJCR.916398 Text en © Am J Case Rep, 2019 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Articles
Fukahori, Susumu
Kawano, Tetsuya
Obase, Yasushi
Umeyama, Yasuhiro
Sugasaki, Nanae
Kinoshita, Akitoshi
Fukushima, Chizu
Yamakawa, Masaki
Omagari, Katsuhisa
Mukae, Hiroshi
Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use
title Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use
title_full Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use
title_fullStr Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use
title_full_unstemmed Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use
title_short Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use
title_sort fluctuation of hepatic focal nodular hyperplasia size with oral contraceptives use
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683308/
https://www.ncbi.nlm.nih.gov/pubmed/31358723
http://dx.doi.org/10.12659/AJCR.916398
work_keys_str_mv AT fukahorisusumu fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse
AT kawanotetsuya fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse
AT obaseyasushi fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse
AT umeyamayasuhiro fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse
AT sugasakinanae fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse
AT kinoshitaakitoshi fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse
AT fukushimachizu fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse
AT yamakawamasaki fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse
AT omagarikatsuhisa fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse
AT mukaehiroshi fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse